Molecular Mechanisms of FOXL2, An Ovarian Failure Gene

卵巢衰竭基因 FOXL2 的分子机制

基本信息

  • 批准号:
    8097122
  • 负责人:
  • 金额:
    $ 16.29万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-08-01 至 2012-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Premature ovarian failure affects up to 1% of women by the age of 40. Although the etiology of premature ovarian failure remains largely unknown, a genetic basis has been determined for selective cases. Mutations in the gene encoding a forkhead transcription, Forkhead L2 (FOXL2) has been associated with this disorder. FOXL2 is present in the ovary and preliminary data reveals that it is localized to less differentiated granulosa cells of small and medium follicles and functions as a transcriptional represser of the Steroidogenic Acute Regulatory (StAR) gene, a marker of granulosa cell differentiation. Since FOXL2 may function as a represser of granulosa cell differentiation and steroidogenesis, we propose to evaluate FOXL2 transcriptional activity on other genes involved in the Steroidogenic cascade which contain putative forkhead consensus sites. Since FOXL2 may function as a represser of granulosa cell differentiation and hence steroidogenesis, we will evaluate steroid production in the granulosa cell following FOXL2 overexpression. In order to understand some of the underlying mechanism of FOXL2 regulation in the ovary, we performed a yeast two-hybrid screen using an ovarian fusion cDNA library to isolate FOXL2-interacting proteins. Large Tumor Suppressor Gene 1 (LATS1), a putative serine/threonine kinase and ovarian tumor suppressor gene, was identified to interact strongly with FOXL2. Mutations in LATS1, like mutations in FOXL2 produce a similar ovarian phenotype, premature ovarian failure. Thus, we propose that LATS1 and FOXL2 share a common pathway for follicular regulation. We will first localize LATS1 in the ovary, followed by defining the precise interaction between LATS1 and FOXL2. Since LATS1 is a serine/threonine kinase, and other forkhead family members are regulated by phosphorylation, we propose that FOXL2 transcriptional activity will be regulated by phosphorylation. Thus, we will also determine phosphorylation of FOXL2 by LATS1 and its regulation of transcriptional activity using our functional assay as well as through cellular localization. The proposed study could provide a better understanding of the mechanisms underlying premature ovarian failure.
描述(由申请人提供):卵巢早衰影响高达1%的40岁女性。尽管卵巢过早衰竭的病因在很大程度上仍不清楚,但已确定某些病例的遗传基础。编码叉头转录的基因中的突变,叉头L2(FOXL 2)与这种疾病相关。FOXL 2存在于卵巢中,初步数据显示,它定位于小型和中型卵泡的分化程度较低的颗粒细胞,并作为类固醇生成急性调节(星星)基因(颗粒细胞分化的标志物)的转录抑制因子发挥作用。由于FOXL 2可能作为颗粒细胞分化和类固醇生成的阻遏物发挥作用,我们建议评估FOXL 2对其他参与类固醇生成级联反应的基因的转录活性,这些基因含有推定的叉头一致位点。由于FOXL 2可能作为颗粒细胞分化的阻遏物,因此类固醇生成,我们将评估FOXL 2过表达后颗粒细胞中类固醇的产生。为了了解卵巢中FOXL 2调控的一些潜在机制,我们使用卵巢融合cDNA文库进行酵母双杂交筛选以分离FOXL 2相互作用蛋白。大肿瘤抑制基因1(LATS 1),一个假定的丝氨酸/苏氨酸激酶和卵巢肿瘤抑制基因,被鉴定为与FOXL 2强烈相互作用。LATS 1突变与FOXL 2突变一样,产生相似的卵巢表型,即卵巢早衰。因此,我们认为LATS 1和FOXL 2共享一个共同的卵泡调节途径。我们将首先在卵巢中定位LATS 1,然后定义LATS 1和FOXL 2之间的精确相互作用。由于LATS 1是一种丝氨酸/苏氨酸激酶,而其他叉头家族成员受磷酸化调控,因此我们认为FOXL 2的转录活性将受磷酸化调控。因此,我们还将使用我们的功能测定以及通过细胞定位来确定LATS 1对FOXL 2的磷酸化及其对转录活性的调节。这项研究可以更好地了解卵巢早衰的机制。

项目成果

期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Sumoylation of forkhead L2 by Ubc9 is required for its activity as a transcriptional repressor of the Steroidogenic Acute Regulatory gene.
  • DOI:
    10.1016/j.cellsig.2009.09.001
  • 发表时间:
    2009-12
  • 期刊:
  • 影响因子:
    4.8
  • 作者:
    Kuo FT;Bentsi-Barnes IK;Barlow GM;Bae J;Pisarska MD
  • 通讯作者:
    Pisarska MD
Expression of forkhead transcription factors in human granulosa cells.
  • DOI:
    10.1016/j.fertnstert.2008.04.054
  • 发表时间:
    2009-04
  • 期刊:
  • 影响因子:
    6.7
  • 作者:
    Pisarska, Margareta D.;Kuo, Fang-Ting;Tang, Dahai;Zarrini, Parham;Khan, Salma;Ketefian, Aline
  • 通讯作者:
    Ketefian, Aline
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Margareta Pisarska其他文献

Margareta Pisarska的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Margareta Pisarska', 18)}}的其他基金

The impact of sex and gender on disease progression, from developmental origins
从发育起源来看性别和性别对疾病进展的影响
  • 批准号:
    10469623
  • 财政年份:
    2020
  • 资助金额:
    $ 16.29万
  • 项目类别:
The impact of sex and gender on disease progression, from developmental origins
从发育起源来看性别和性别对疾病进展的影响
  • 批准号:
    10687088
  • 财政年份:
    2020
  • 资助金额:
    $ 16.29万
  • 项目类别:
The impact of sex and gender on disease progression, from developmental origins
从发育起源来看性别和性别对疾病进展的影响
  • 批准号:
    10062754
  • 财政年份:
    2020
  • 资助金额:
    $ 16.29万
  • 项目类别:
The impact of sex and gender on disease progression, from developmental origins
从发育起源来看性别和性别对疾病进展的影响
  • 批准号:
    10260551
  • 财政年份:
    2020
  • 资助金额:
    $ 16.29万
  • 项目类别:
Non-Invasive Prenatal Diagnostics Based on Circulating Trophoblasts
基于循环滋养细胞的无创产前诊断
  • 批准号:
    10675005
  • 财政年份:
    2019
  • 资助金额:
    $ 16.29万
  • 项目类别:
Non-Invasive Prenatal Diagnostics Based on Circulating Trophoblasts
基于循环滋养细胞的无创产前诊断
  • 批准号:
    10252913
  • 财政年份:
    2019
  • 资助金额:
    $ 16.29万
  • 项目类别:
Noncoding RNA regulation of the human placental transcriptome among the sexes
性别中人胎盘转录组的非编码RNA调控
  • 批准号:
    9308742
  • 财政年份:
    2017
  • 资助金额:
    $ 16.29万
  • 项目类别:
Adverse Outcomes of Assisted Reproductive Technologies: Genetics or Epigenetics?
辅助生殖技术的不良后果:遗传学还是表观遗传学?
  • 批准号:
    8529827
  • 财政年份:
    2013
  • 资助金额:
    $ 16.29万
  • 项目类别:
Adverse Outcomes of Assisted Reproductive Technologies: Genetics or Epigenetics?
辅助生殖技术的不良后果:遗传学还是表观遗传学?
  • 批准号:
    9067824
  • 财政年份:
    2013
  • 资助金额:
    $ 16.29万
  • 项目类别:
Adverse Outcomes of Assisted Reproductive Technologies: Genetics or Epigenetics?
辅助生殖技术的不良后果:遗传学还是表观遗传学?
  • 批准号:
    8735977
  • 财政年份:
    2013
  • 资助金额:
    $ 16.29万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.29万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 16.29万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.29万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.29万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.29万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.29万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.29万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 16.29万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 16.29万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 16.29万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了